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Introduction
Myasthenia gravis (MG) is an acquired neuromuscu-
lar disorder, characterized by fluctuating weakness of
the skeletal muscles, particularly those innervated by
motor nuclei of the brainstem. The disorder produces
a decrease in the number of acetylcholine receptors in
the neuromuscular plates, due to an autoimmune pro-
cess mediated by antibodies against the alpha subunit
of the nicotine receptor of acetylcholine. Patients with
MG have a higher incidence of other autoimmune
diseases, such as thyroid diseases, polymyositis, systemic
lupus erythematosus, and rheumatoid arthritis. The
most frequently associated condition is autoimmune
thyroid disease, which is present in 5–10% of patients
with MG.1 However, only 0.2% of patients with thy-
roid disease have MG, with thyrotoxicosis as the most
common among them. Hypothyroidism is rare. In the
report of Téllez-Zenteno et al, associated conditions
in MG accounted for about 26% of the cases, and
among them, the incidence of hypothyroidism was
less than half the incidence of hyperthyroidism (14%
vs. 33%).2 Herein, we present an MG patient with
thymoma and coexistent central hypothyroidism, who
benefited from the correction of hypothyroidism by
thyroxine sodium (eltroxin) supplementation.
Case Report 
An 82-year-old married man had hypertension for
more than 10 years and received regular medications
with good control. One month before admission, he
complained of weakness when grasping objects, extend-
ing his fingers and after prolonged mastication. The
symptoms occurred mostly in the afternoon; no promi-
nent fluctuating course was noted, and the patient felt
better after resting. He did not complain of muscle
aches or cramps after exertion. Two weeks before ad-
mission, he developed drooping of his left eyelid, and
a positive intravenous vasostigmine test was noted.
Progressive exertional dyspnea and orthopnea were
observed in the ongoing 1 week.
Physical examination showed an awake, well-
nourished but acutely ill-looking patient, with tachy-
pnea (30 per minute) and exertional dyspnea without
wheezing, rhonchi or rales. There were no limb edema,
cyanosis, or clubbed fingers. Neurologic examination
showed weakness of all 4 limbs but symmetrical mus-
cle power grading of 4/5 in both distal and proximal
portions. Prominent weakness of neck flexors and
extensors with grades of 2/5 and 3/5 respectively were
also noted. Light reflexes, eye accommodation, other
brainstem reflexes, swallowing capability and all the
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sensory modalities were intact. Symmetrically brief
knee and biceps jerks were noted. There were no upper
motor neuron signs, no fasciculations, no myotonia,
no muscle hypertrophy and no muscle tenderness.
Laboratory data revealed no significant findings in
routine blood tests and biochemistry study. The acetyl-
choline receptor antibody using radioimmunoassay
was 45.3 nmol/L (normal < 0.2 nmol/L). No hypox-
emia or hypercapnia was noted. Noncontrast chest com-
puted tomography (CT) disclosed a soft tissue density
measuring about 13 × 4.6 × 2.3 cm in size at the ante-
rior mediastinum. Repetitive stimulation of peripheral
nerves (including facial, median and ulnar nerves) at a
rate of 3 per second showed significant decremental
responses (Table 1).
Double-filtration plasmapheresis was started for 5
consecutive sessions, and postprandial oral pyridostig-
mine 60 mg thrice a day and oral prednisolone 5 mg
twice a day were also given simultaneously. Intravenous
methylprednisolone 1,000 mg was given on the day
of admission and in the perioperative period. About
11 days after admission, the patient underwent maximal
thymectomy via a trans-sternal approach. Histopatho-
logic examination showed a multilocular thymic cyst
with multifoci of type A thymoma, and no evidence of
malignancy was seen. The endotracheal tube (ET) was
removed smoothly after recovery of consciousness on
the same day of operation. Neurologically, the patient
showed no focal limb weakness and no swallowing
difficulty, but marked weakness in neck flexors and
extensors were noted as on admission.
On the 6th postoperative day, he became drowsy,
and arterial blood gas showed hypercapnia (57 mmHg)
without hypoxemia. He regained consciousness soon
after intubation of ET tube with ventilator support.
Plasmapheresis was restarted for 3 consecutive sessions,
along with increased dosage of pyridostigmine to
240 mg and prednisolone to 20 mg a day. On the 10th
postoperative day, the patient was weaned from the
ventilator, but a similar event occurred 3 days after extu-
bation and arterial blood gas again disclosed hypercap-
nia (45 mmHg) that soon resolved after re-intubation
of ET tube with ventilator support. Stationary neuro-
logic deficits were noted.
Possible associated conditions of MG were surveyed
due to repeated failure of weaning from ventilator with
ensuing hypercapnia. The results showed low levels of
total triiodothyronine (T3; 0.49 ng/mL; normal, 0.7–
1.7 ng/mL), total thyroxine (T4; 1.90 μg/dL; normal,
4.5–12.5 μg/dL), and free thyroxine (FT4; 0.45 ng/
dL; normal, 0.89–1.8 ng/dL), but normal levels of
thyroid-stimulating hormone (TSH; 1.07 μIU/mL;
normal, 0.4–4 μIU/mL), prolactin, ACTH, cortisol,
follicle-stimulating hormone, luteinizing hormone, ery-
throcyte sedimentation rate, and immunoglobulins
(IgA, IgG, IgM). Antinuclear antibody and rheumatoid
factors were negative. Consultation with an endocrinol-
ogist confirmed the central origin of hypothyroidism.
Magnetic resonance imaging (MRI) of the brain
showed a small pituitary gland with widened empty
pituitary fossa (empty sella) and no abnormal contrast
enhancement. There was no evidence of other poly-
glandular autoimmune diseases, which was confirmed
after an evaluation by a rheumatologist. Eltroxin sup-
plement with 100 μg daily was given along with respi-
ratory training rehabilitation. Dramatic responses were
noted 5 days later. The patient regained full muscle
power of neck flexors and extensors and was weaned
from the ventilator successfully. The serum level of
T4 (8.0 μg/dL) and FT4 (2.05 ng/dL) normalized,
although T3 level remained at the lower limit of nor-
mal (0.62 ng/mL). TSH (1.9 μIU/mL), cortisol and
ACTH remained within normal limits after repeated
check-up.
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Table 1. Repetitive stimulation of peripheral nerves at a rate of 3 per second on admission and on the 45th postoperative day
On admission Postoperatively
Muscle
Ampl (mV) AMP4 (%) AMP10 (%) Ampl (mV) AMP4 (%) AMP10 (%)
Right
APB 12.4 −20.2 −19.1 10.5 −5.3 −8.2
ADM 10.4 −16.1 −18.4 7.4 −4.6 3.6
Nasalis 1.1 −48.2 −43.2 1.3 −4.1 −3.1
Left
APB 9.4 −22.1 −17.8 7.0 −2.7 0.8
ADM 9.3 −21.2 −15.4 6.7 2.9 1.2
Nasalis 0.8 −36.5 −32.7 1.6 1.1 0.8
APB = abductor pollicis brevis; ADM = abductor digiti minimi; Ampl = amplitude; AMP4 = difference in amplitude of wave 4; AMP10 = difference in amplitude
of wave 10.
Repetitive stimulation of peripheral nerves was 
repeated 45 days after operation, and revealed no
decremental responses (Table 1). The patient was able
to live independently. Medications were continued with
oral prednisolone 10 mg, pyridostigmine 180 mg and
eltroxin 50 μg a day.
Discussion
We present a patient with definite MG who had thy-
moma that coexisted with central hypothyroidism.
Whether the coexistence of hypothyroidism plays a
major role in the clinical expression or plays an adjunc-
tive role is not well known. Since the positive intra-
venous vasostigmine result, elevated serum acetylcholine
receptor antibody, significant decremental responses
at 3-Hz repetitive stimulation test, anterior mediastinal
mass by CT scan, and histopathologic findings all con-
firmed the diagnosis of MG with thymoma, we did not
pursue further surveying for possible associated con-
ditions. Fortunately, this overlook did not result in any
irreversible harm to the patient. Instead, it helped us
prove that the correction of hypothyroidism is manda-
tory for complete remission of MG. This seems to con-
tradict the findings of De Assis et al, who suggested that
“there is no clinical correlation between both myasthe-
nia symptomatology and thyroid dysfunction, neither
significant influence on myasthenic symptoms when
the endocrine disorders improve”.3
The main symptoms related to hypothyroidism are
proximal muscle weakness, muscle cramps, and myalgia,
which were lacking in our patient, except for the promi-
nent neck and respiratory muscle weakness. It was also
observed that the patient could not be weaned from
the ventilator successfully without thyroxin supplemen-
tation. Proximal myopathy may rarely be seen as the
sole manifestation of hypothyroidism. However, in our
patient, the initial manifestations were distal muscle
weakness and preserved deep tendon reflexes without
evidence of myxedema. These initial manifestations
seemed to have no correlation with hypothyroidism,
hence, an “atypical” condition was more favored. Severe
muscular weakness of acute onset is relatively rare and
is encountered in approximately 1% of hypothyroid
patients.4 Conversely, we may not see improvement in
spite of thyroxine supplementation without sufficient
treatment directed toward MG. In our patient, we were
able to achieve complete remission with the proper man-
agement of MG and correction of hypothyroidism.
Central hypothyroidism is caused by impaired stim-
ulation of a normal thyroid gland by hypothalamic 
or pituitary hormones via various etiologies,5 and
pituitary adenomas are the most common cause.6 The
etiopathogenic relationship between the thymus and
MG is variable and complex, and immunopathologic
as well as immunogenetic possibilities have been 
proposed. Kuroda et al7 described a case of exacerba-
tion of myasthenia after removal of a thymoma having
a membrane phenotype of suppressor T-cells, while
Ghiringhelli et al8 suggested that the onset of myas-
thenia can be attributed to the withdrawal, following
surgery, of the inhibitory effects of the thymoma on
some clones of autoreactive lymphocytes. But in a large
series study, regarding thymectomy for MG with asso-
ciated conditions, no differences were found between
patients with and without associated conditions in their
clinical data, complications, and response to thymec-
tomy.2 A multifactorial study clarified the prognostic
factors in thymoma, and found that staging was of the
greatest usefulness in predicting the biological behav-
ior of thymoma, and other clinicopathologic features
(age, sex, tumor size, presence of MG, epithelial sub-
typing, and lymphocyte/epithelial cell ratio) have no
definite influence on survival expectancy.9
In our patient, the reason for the pure selective pitui-
tary dysfunction is not clear, and clinical follow-up to
search for other possible associated autoimmune diseases
should be kept in mind in the future. Surveying of asso-
ciated conditions in every MG patient should be done
routinely even though definite thymoma is present.
Correction of the associated conditions is mandatory
and may be significant in the achievement of remission.
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